DELIVERING HEALTH INFORMATION
YOU CAN TRUST SINCE 1989
Join the enews community - Terms
MEMBER
MENU
Filter by Categories
Blog
General
Lifestyle

Google has shares in blood-clot Covid vaccine developer

Reading time: 1 minute
Google has shares in blood-clot Covid vaccine developer

Google has shares in a biotech company that developed the controversial AstraZeneca Covid-19 vaccine that has been banned in several countries because of an increased risk of life-threatening blood clots.

Its venture capital arm, Google Ventures, has a 6 percent holding in Vaccitech (UK) Ltd, the developer of the AstraZeneca/Oxford University jab, which has been banned or its use restricted in most countries in Europe. Health agencies have also changed their safety advisory and recommend people under the age of 30 are offered an alternative vaccine.

The risk has been estimated at around one case per 100,000 people vaccinated, similar to blood-clotting risks with the contraceptive pill.

Google’s interest in Vaccitech came to light when the company issued its prospectus to raise $125 million on the US stock market. It started investing in the company in 2017.

(Source: Vaccitech prospectus, filed with the Securities Exchange Commission, April 9, 2021)

What do you think? Start a conversation over on the... WDDTY Community

  • Recent Posts

  • Copyright © 1989 - 2024 WDDTY
    Publishing Registered Office Address: Hill Place House, 55a High Street Wimbledon, London SW19 5BA
    Skip to content